A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma-Reference-Cited by-同舟云学术

A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

Published:2007-12 Issue:11 Volume:176 Page:1062-1071
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Flood-Page Patrick,Swenson Cheri,Faiferman Isidore,Matthews John,Williams Michael,Brannick Lesley,Robinson Douglas,Wenzel Sally,Busse William,Hansel Trevor T.,Barnes Neil C.,

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference40 articles.

1. Cationic Proteins Induce Airway Hyperresponsiveness Dependent on Charge Interactions

2. New insights into the relationship between airway inflammation and asthma

3. Eosinophilic Inflammation in Asthma

4. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.

5. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.Blood1992;79:2952–2959.

Cited by 663 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety of monoclonal antibodies in chronic inflammatory airway diseases (chronic sinusitis with nasal polyposis and asthma): A network meta-analysis;International Immunopharmacology;2024-09

2. Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways;Immunological Reviews;2024-08-19

3. Eosinophils and T2 inflammation in severe asthma;Exploration of Asthma & Allergy;2024-08-13

4. De l’asthme difficile à traiter à l’asthme sévère : palier 5;Revue des Maladies Respiratoires;2024-08

5. Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease;Nature Reviews Immunology;2024-07-09